← Leaderboards
Frank M Balis
Clinical Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Clinical Sciences
Same institution · by research overlap
- Jane B Trepel$0
- Brigitte Widemann$0
- Maria Tsokos$0
- Susan Bates$0
- Edward A Sausville$6,399,210
Others in their field
Top investigators on “Nucleoside Analog”
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Robert Turner Schooley · University Of Colorado Denver$49,550,018
- Jeffrey S Glenn · Stanford University$19,514,752
- Ruth Martha Greenblatt · University Of California San Francisco$19,382,210
- Vern L. Schramm · Yeshiva University$18,631,228
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
Research focus
Nucleoside AnalogDrug Screening /EvaluationIonophoresHuman SubjectBlood Brain BarrierChemical Structure FunctionNeoplasm /Cancer PharmacologyPediatric Neoplasm /CancerPteridine AnalogFluorescent Dye /ProbeAntineoplasticsPharmacokineticsDrug Design /Synthesis /ProductionBrain NeoplasmsPediatric PharmacologyBrain Imaging /Visualization /ScanningIntegraseIntermolecular InteractionClinical TrialsNucleic Acid ProbesHuman Therapy EvaluationIndustryMicrodialysisNeoplasm /Cancer Chemotherapy
Grant awards (18)
Anticancer Drug Development for Childhood Cancers$1,123,517
Z01 · FY2008 · CA · contact PI
Fluorescent Pteridine Nucleoside Analogs$124,835
Z01 · FY2008 · CA · contact PI
Drug Development and Clinical Pharmacology of Anticancer Drugs for Childhood Can$2,427,257
Z01 · FY2007 · CA · contact PI
Fluorescent Pteridine Nucleoside Analogs$121,957
Z01 · FY2007 · CA · contact PI
Drug Development and Clinical Pharmacology of Anticancer$0
Z01 · FY2006 · SC · contact PI
Fluorescent Pteridine Nucleoside Analogs$0
Z01 · FY2006 · SC · contact PI
Fluorescent Pteridine Nucleoside Analogs$0
Z01 · FY2005 · SC
Drug Development and Clinical Pharmacology of Anticancer$0
Z01 · FY2005 · SC
Drug Development &Clinical Pharma. of Anticancer Drugs$0
Z01 · FY2004 · SC
Fluorescent Pteridine Nucleoside Analogs$0
Z01 · FY2004 · SC
Fluorescent Pteridine Nucleoside Analogs$0
Z01 · FY2003 · SC
Drug Development and Clinical Pharmacology of Anticancer$0
Z01 · FY2003 · SC
Fluorescent Pteridine Nucleoside Analogs$0
Z01 · FY2002 · SC
Drug Development and Clinical Pharmacology of Anticancer$0
Z01 · FY2002 · SC
Fluorescent Pteridine Nucleoside Analogs$0
Z01 · FY2001 · SC
Drug Development and Clinical Pharmacology of Anticancer$0
Z01 · FY2001 · SC
DRUG DEVELOPMENT &CLINICAL PHARMACOLOGY OF ANTICANCER D$0
Z01 · FY2000 · SC
Fluorescent Pteridine Nucleoside Analogs$0
Z01 · FY2000 · SC